Angiotensin-converting-enzyme inhibitors in early pregnancy

Lip and Churchill conclude that angiotensin-converting-enzyme inhibitors taken at the time of conception or during early pregnancy do not necessarily carry an adverse outlook as long as these drugs are discontinued as soon as possible.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1997-11, Vol.350 (9089), p.1446-1447
Main Authors: Lip, Gregory YH, Churchill, David, Beevers, Michèle, Auckett, Ann, Beevers, D Gareth
Format: Article
Language:English
Subjects:
Adult
Angiotensin-Converting Enzyme Inhibitors - adverse effects
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antihypertensive Agents - adverse effects
Antihypertensive Agents - therapeutic use
Biological and medical sciences
Contraindications
Drug therapy
Drug toxicity and drugs side effects treatment
Enzyme inhibitors
Female
Humans
Hypertension - drug therapy
Medical sciences
Pharmacology. Drug treatments
Pregnancy
Pregnancy Trimester, First
Retrospective Studies
Risk Factors
Side effects
Toxicity: osteoarticular system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lip and Churchill conclude that angiotensin-converting-enzyme inhibitors taken at the time of conception or during early pregnancy do not necessarily carry an adverse outlook as long as these drugs are discontinued as soon as possible.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(05)64207-9